Human Monoclonal Antibodies as Adjuvant Treatment of Chronic Hepatitis B Virus Infection

Human Monoclonal Antibodies as Adjuvant Treatment of Chronic Hepatitis B Virus Infection

Despite the availability of an effective prophylactic vaccine leading to sterilizing immunity, hepatitis B virus (HBV) is responsible for chronic liver disease in more than 250 million individuals, potentially leading to cirrhosis and hepatocellular carcinoma. Antiviral drugs able to completely supp...

Full description

Bibliographic Details
Main Authors: Antonella Cerino, Stefania Mantovani, Dalila Mele, Barbara Oliviero, Stefania Varchetta, Mario U. Mondelli
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-09-01
Series:Frontiers in Immunology
Subjects:
human monoclonal antibody
HBV—hepatitis B virus
B cells
immune system
adaptive immunity
Online Access:https://www.frontiersin.org/article/10.3389/fimmu.2019.02290/full

Similar Items

Similar Items